FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2169726711> ?p ?o ?g. }

• W2169726711 endingPage "31" @default.
• W2169726711 startingPage "25" @default.
• W2169726711 abstract "Cognitive dysfunction is a key predictor of functional disability in schizophrenia. Davunetide (AL-108, NAP) is an intranasally administered peptide currently being developed for treatment of Alzheimer's disease and related disorders. This study investigates effects of davunetide on cognition in schizophrenia.Sixty-three subjects with schizophrenia received davunetide at one of two different doses (5, 30 mg) or placebo for 12 weeks in a multicenter, double-blind, parallel-group randomized clinical trial. The MATRICS Consensus Cognitive Battery (MCCB) assessed cognitive effects. The UCSD Performance-based Skills Assessment (UPSA) and the Schizophrenia Cognition Rating Scale (SCoRS) assessed functional capacity. Subjects continued their current antipsychotic treatment during the trial.There were no significant differences in MCCB change between davunetide and placebo over the three treatment arms (p=.45). Estimated effect-size (d) values were .34 and .21 favoring the 5 and 30 mg doses vs. placebo, respectively. For UPSA, there was a significant main effect of treatment across study arms (p=.048). Between-group effect size (d) values were.74 and .48, favoring the 5 and 30 mg doses, respectively. No significant effects were observed on the SCoRS or on symptom ratings. No significant side effects or adverse events were observed.Davunetide was well tolerated. Effects of davunetide on MCCB-rated cognition were not significant relative to placebo. In contrast, a significant beneficial effect was detected for the UPSA. Based upon effect-size considerations, sample sizes of at least 45-50 subjects/group would be required to obtain significant effects on both MCCB and UPSA, providing guidance for continued clinical development in schizophrenia." @default.
• W2169726711 created "2016-06-24" @default.
• W2169726711 creator A5001174590 @default.
• W2169726711 creator A5003154905 @default.
• W2169726711 creator A5014156593 @default.
• W2169726711 creator A5014788779 @default.
• W2169726711 creator A5018822834 @default.
• W2169726711 creator A5026643447 @default.
• W2169726711 creator A5028131133 @default.
• W2169726711 creator A5035272094 @default.
• W2169726711 creator A5045314404 @default.
• W2169726711 creator A5045818277 @default.
• W2169726711 creator A5053602165 @default.
• W2169726711 creator A5068127710 @default.
• W2169726711 creator A5070223359 @default.
• W2169726711 creator A5070720166 @default.
• W2169726711 creator A5071536045 @default.
• W2169726711 creator A5072481624 @default.
• W2169726711 creator A5075093461 @default.
• W2169726711 creator A5082297204 @default.
• W2169726711 creator A5088564036 @default.
• W2169726711 date "2012-04-01" @default.
• W2169726711 modified "2023-10-03" @default.
• W2169726711 title "Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia" @default.
• W2169726711 cites W129687238 @default.
• W2169726711 cites W1968763887 @default.
• W2169726711 cites W1983603621 @default.
• W2169726711 cites W1998420327 @default.
• W2169726711 cites W2001513801 @default.
• W2169726711 cites W2002192892 @default.
• W2169726711 cites W2007298996 @default.
• W2169726711 cites W2010908328 @default.
• W2169726711 cites W2020844317 @default.
• W2169726711 cites W2037673991 @default.
• W2169726711 cites W2070996265 @default.
• W2169726711 cites W2081878543 @default.
• W2169726711 cites W2089153987 @default.
• W2169726711 cites W2104387947 @default.
• W2169726711 cites W2110286211 @default.
• W2169726711 cites W2119365346 @default.
• W2169726711 cites W2121914065 @default.
• W2169726711 cites W2124001849 @default.
• W2169726711 cites W2128456675 @default.
• W2169726711 cites W2132964759 @default.
• W2169726711 cites W2133245655 @default.
• W2169726711 cites W2136125607 @default.
• W2169726711 cites W2136172091 @default.
• W2169726711 cites W2146264275 @default.
• W2169726711 cites W2151080668 @default.
• W2169726711 cites W2151852857 @default.
• W2169726711 cites W2160997964 @default.
• W2169726711 cites W2165379748 @default.
• W2169726711 cites W2165955750 @default.
• W2169726711 cites W2167614851 @default.
• W2169726711 cites W3026558616 @default.
• W2169726711 doi "https://doi.org/10.1016/j.schres.2011.11.001" @default.
• W2169726711 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22169248" @default.
• W2169726711 hasPublicationYear "2012" @default.
• W2169726711 type Work @default.
• W2169726711 sameAs 2169726711 @default.
• W2169726711 citedByCount "105" @default.
• W2169726711 countsByYear W21697267112012 @default.
• W2169726711 countsByYear W21697267112013 @default.
• W2169726711 countsByYear W21697267112014 @default.
• W2169726711 countsByYear W21697267112015 @default.
• W2169726711 countsByYear W21697267112016 @default.
• W2169726711 countsByYear W21697267112017 @default.
• W2169726711 countsByYear W21697267112018 @default.
• W2169726711 countsByYear W21697267112019 @default.
• W2169726711 countsByYear W21697267112020 @default.
• W2169726711 countsByYear W21697267112021 @default.
• W2169726711 countsByYear W21697267112022 @default.
• W2169726711 countsByYear W21697267112023 @default.
• W2169726711 crossrefType "journal-article" @default.
• W2169726711 hasAuthorship W2169726711A5001174590 @default.
• W2169726711 hasAuthorship W2169726711A5003154905 @default.
• W2169726711 hasAuthorship W2169726711A5014156593 @default.
• W2169726711 hasAuthorship W2169726711A5014788779 @default.
• W2169726711 hasAuthorship W2169726711A5018822834 @default.
• W2169726711 hasAuthorship W2169726711A5026643447 @default.
• W2169726711 hasAuthorship W2169726711A5028131133 @default.
• W2169726711 hasAuthorship W2169726711A5035272094 @default.
• W2169726711 hasAuthorship W2169726711A5045314404 @default.
• W2169726711 hasAuthorship W2169726711A5045818277 @default.
• W2169726711 hasAuthorship W2169726711A5053602165 @default.
• W2169726711 hasAuthorship W2169726711A5068127710 @default.
• W2169726711 hasAuthorship W2169726711A5070223359 @default.
• W2169726711 hasAuthorship W2169726711A5070720166 @default.
• W2169726711 hasAuthorship W2169726711A5071536045 @default.
• W2169726711 hasAuthorship W2169726711A5072481624 @default.
• W2169726711 hasAuthorship W2169726711A5075093461 @default.
• W2169726711 hasAuthorship W2169726711A5082297204 @default.
• W2169726711 hasAuthorship W2169726711A5088564036 @default.
• W2169726711 hasConcept C118552586 @default.
• W2169726711 hasConcept C126322002 @default.
• W2169726711 hasConcept C138496976 @default.
• W2169726711 hasConcept C142724271 @default.
• W2169726711 hasConcept C15744967 @default.

• next